Skip to main content
Erschienen in: Acta Neurochirurgica 2/2012

01.02.2012 | Clinical Article

5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study

verfasst von: Marcel A. Kamp, Philipp Grosser, Jörg Felsberg, Philipp J. Slotty, Hans-Jakob Steiger, Guido Reifenberger, Michael Sabel

Erschienen in: Acta Neurochirurgica | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Microsurgical, circumferential stripping of intracerebral metastases often proves to be insufficient to prevent local tumor recurrence.

Objective

We were interested in the potential impact of 5-aminolevulinic acid (5-ALA)-induced-fluorescence (5-AIF) as a diagnostic tool for the resection of intracerebral metastases.

Methods

A retrospective analysis was performed for 52 patients who underwent 5-AIF-guided resection for intracerebral mass lesions that histologically corresponded to metastases from tumors outside the central nervous system. The presence of ALA fluorescence in the tumor was determined in each patient. In 42 patients, fluorescence of the resection cavity after tumor removal was additionally recorded. Data were correlated with neuropathological findings in tissue specimens.

Results

A total of 32 of the 52 metastases (62%) exhibited 5-AIF in tumor parts. All 5-AIF-positive metastases exhibited an inhomogeneous fluorescence pattern. 5-AIF was neither associated with the histological type nor with the site of origin of the metastases. Residual fluorescence of the resection cavity was detected after macroscopically complete white light resection in 24 patients with 5-AIF positive metastases. Residual tumor tissue was histologically confirmed in 6 of 18 patients with available tissue specimens from such 5-AIF positive areas (33%).

Conclusions

The majority of metastases (62%) were 5-AIF positive, suggesting a potential impact of 5-AIF for improved visualization of metastatic tumor tissue within the brain. However, residual 5-AIF after macroscopically complete resection of a metastasis needs to be interpreted with caution because of the limited specificity for detection of residual tumor tissue.
Literatur
1.
Zurück zum Zitat Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M (2006) Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 129(3):718–724PubMedCrossRef Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M (2006) Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 129(3):718–724PubMedCrossRef
2.
Zurück zum Zitat Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66(1):187–194PubMedCrossRef Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66(1):187–194PubMedCrossRef
3.
Zurück zum Zitat Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85(12):1301–1307PubMedCrossRef Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85(12):1301–1307PubMedCrossRef
4.
Zurück zum Zitat Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19(2):223–229PubMedCrossRef Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19(2):223–229PubMedCrossRef
6.
Zurück zum Zitat Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Wilhelm, Kreth F, Pietsch T, Loeffler M, Weller M, Reifenberger G and Tonn JC (2011) Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6, and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Wilhelm, Kreth F, Pietsch T, Loeffler M, Weller M, Reifenberger G and Tonn JC (2011) Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6, and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer
7.
Zurück zum Zitat Gamarra F, Lingk P, Marmarova A, Edelmann M, Hautmann H, Stepp H, Baumgartner R, Huber RM (2004) 5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion. J Photochem Photobiol B 73(1–2):35–42PubMedCrossRef Gamarra F, Lingk P, Marmarova A, Edelmann M, Hautmann H, Stepp H, Baumgartner R, Huber RM (2004) 5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion. J Photochem Photobiol B 73(1–2):35–42PubMedCrossRef
8.
Zurück zum Zitat Grimbergen MC, van Swol CF, van Moorselaar RJ, Uff J, Mahadevan-Jansen A, Stone N (2009) Raman spectroscopy of bladder tissue in the presence of 5-aminolevulinic acid. J Photochem Photobiol B 95(3):170–176PubMedCrossRef Grimbergen MC, van Swol CF, van Moorselaar RJ, Uff J, Mahadevan-Jansen A, Stone N (2009) Raman spectroscopy of bladder tissue in the presence of 5-aminolevulinic acid. J Photochem Photobiol B 95(3):170–176PubMedCrossRef
9.
Zurück zum Zitat Huber RM, Gamarra F, Hautmann H, Häußinger R, Wagner S, Castro M, Baumgartner R (1999) 5-Aminolaevulinic Acid (ALA) for the fluorescence detection of bronchial tumors. Diagn Ther Endosc 5:113–118PubMedCrossRef Huber RM, Gamarra F, Hautmann H, Häußinger R, Wagner S, Castro M, Baumgartner R (1999) 5-Aminolaevulinic Acid (ALA) for the fluorescence detection of bronchial tumors. Diagn Ther Endosc 5:113–118PubMedCrossRef
10.
Zurück zum Zitat Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M (2011) Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 47(5):649–655PubMedCrossRef Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M (2011) Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 47(5):649–655PubMedCrossRef
11.
Zurück zum Zitat Kemmner W, Wan K, Ruttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22(2):500–509PubMedCrossRef Kemmner W, Wan K, Ruttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22(2):500–509PubMedCrossRef
12.
Zurück zum Zitat Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7(3):283–289PubMedCrossRef Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7(3):283–289PubMedCrossRef
13.
Zurück zum Zitat Leonhard M (1999) New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diagn Ther Endosc 5:71–75PubMedCrossRef Leonhard M (1999) New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diagn Ther Endosc 5:71–75PubMedCrossRef
14.
Zurück zum Zitat Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR (2004) Regulation of ferrochelatase gene expression by hypoxia. Life Sci 75(17):2035–2043PubMedCrossRef Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR (2004) Regulation of ferrochelatase gene expression by hypoxia. Life Sci 75(17):2035–2043PubMedCrossRef
15.
Zurück zum Zitat Neves S, Mazal PR, Wanschitz J, Rudnay AC, Drlicek M, Czech T, Wustinger C, Budka H (2001) Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. Clin Neuropathol 20(1):38–42PubMed Neves S, Mazal PR, Wanschitz J, Rudnay AC, Drlicek M, Czech T, Wustinger C, Budka H (2001) Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. Clin Neuropathol 20(1):38–42PubMed
16.
Zurück zum Zitat Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025–1034PubMedCrossRef Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025–1034PubMedCrossRef
17.
Zurück zum Zitat Stummer W, Hassan A, Kempski O, Goetz C (1996) Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 36(2):179–181PubMedCrossRef Stummer W, Hassan A, Kempski O, Goetz C (1996) Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 36(2):179–181PubMedCrossRef
18.
Zurück zum Zitat Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef
19.
Zurück zum Zitat Teng L, Nakada M, Zhao SG, Endo Y, Furuyama N, Nambu E, Pyko IV, Hayashi Y, Hamada JI (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer 104(5):798–807PubMedCrossRef Teng L, Nakada M, Zhao SG, Endo Y, Furuyama N, Nambu E, Pyko IV, Hayashi Y, Hamada JI (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer 104(5):798–807PubMedCrossRef
20.
Zurück zum Zitat Utsuki S, Miyoshi N, Oka H, Miyajima Y, Shimizu S, Suzuki S, Fujii K (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24(2):53–55PubMedCrossRef Utsuki S, Miyoshi N, Oka H, Miyajima Y, Shimizu S, Suzuki S, Fujii K (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24(2):53–55PubMedCrossRef
21.
Zurück zum Zitat Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, Zo JI, Lee SH (2009) Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 110(4):730–736PubMedCrossRef Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, Zo JI, Lee SH (2009) Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 110(4):730–736PubMedCrossRef
22.
Zurück zum Zitat Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knuechel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief CG (2008) Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid–first clinical experiences. Urology 72(2):345–348PubMedCrossRef Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knuechel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief CG (2008) Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid–first clinical experiences. Urology 72(2):345–348PubMedCrossRef
Metadaten
Titel
5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study
verfasst von
Marcel A. Kamp
Philipp Grosser
Jörg Felsberg
Philipp J. Slotty
Hans-Jakob Steiger
Guido Reifenberger
Michael Sabel
Publikationsdatum
01.02.2012
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 2/2012
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-011-1200-5

Weitere Artikel der Ausgabe 2/2012

Acta Neurochirurgica 2/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.